Protein profiling of pleural effusions to identify malignant pleural mesothelioma using SELDI-TOF MS. - Test2 - elhamkhani - TriplyDB

Protein profiling of pleural effusions to identify malignant pleural mesothelioma using SELDI-TOF MS.

Protein profiling of pleural effusions to identify malignant pleural mesothelioma using SELDI-TOF MS.

http://www.wikidata.org/entity/Q33503319

about

Application of proteomics to soft tissue sarcomas Identification of apolipoprotein C-I as a potential Wilms' tumor marker after excluding inflammatory factors Proteomic profiling for peritoneal dialysate: differential protein expression in diabetes mellitus Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma The role of HE4 in ovarian cancer: inhibiting tumour cell proliferation and metastasis.Proteomic characterization of pediatric craniopharyngioma intracystic fluid by LC-MS top-down/bottom-up integrated approaches.Serum and bronchial aspiration fluid HE-4 levels in lung cancer Comparative proteomic analysis of malignant pleural mesothelioma evidences an altered expression of nuclear lamin and filament-related proteins

P2860

Q28385995-8F7A3D0E-7750-4E39-A145-F31E51777132 Q34358608-1E6CC629-9752-4471-9F37-C0F425230881 Q36921734-C78F43F3-2E26-437C-8A28-A5DAA7ECE3A7 Q37623620-128116CC-9CCD-4DE3-B950-7B5AE88C536C Q39437253-2EAE8D6C-6C00-49A9-A9FF-624E224E3793 Q44190698-C7D316C6-21E4-4FE9-BFDB-75235FCDCB33 Q56945706-F5959ED9-BAA0-44A8-90BB-6D3D0FC0113B Q59033566-E8E11A11-1F88-43C8-B97B-D8888B812949

P2860

Protein profiling of pleural effusions to identify malignant pleural mesothelioma using SELDI-TOF MS.

http://www.wikidata.org/entity/Q33503319

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Protein profiling of pleural e ...... sothelioma using SELDI-TOF MS.

@ast

Protein profiling of pleural e ...... sothelioma using SELDI-TOF MS.

@en

type

label

Protein profiling of pleural e ...... sothelioma using SELDI-TOF MS.

@ast

Protein profiling of pleural e ...... sothelioma using SELDI-TOF MS.

@en

prefLabel

Protein profiling of pleural e ...... sothelioma using SELDI-TOF MS.

@ast

Protein profiling of pleural e ...... sothelioma using SELDI-TOF MS.

@en

P1433

Q33503319-6EDE2DCD-F8F3-4E49-99A6-F0C83EA04F53

P1476

Q33503319-33D9EB8E-BEA2-40AC-8B62-04A5ADABC2DD

P2093

Q33503319-144DFB1E-0A5F-4491-BF7F-5E7D58167003

Q33503319-34BD8C29-F99B-4F46-8C52-9E4C97897B79

Q33503319-3AB9F533-43A2-4B43-9B99-6E280A44E27C

Q33503319-4BF6CCF0-80B8-42C0-AC97-1D18C3C5E53E

Q33503319-5124CE0E-8686-44A1-8D4D-1C053615F7D8

Q33503319-5C973D9D-D207-44C0-9DBC-4AA52B08D93E

Q33503319-60C5036B-047E-4695-8626-BDF4C02B4A9C

Q33503319-7057706E-B001-44E7-B369-80FE6D544ADB

Q33503319-7213CE74-C4E7-40E0-AC74-C1988122AE0A

Q33503319-9E327CF2-8576-411E-9163-676E5F3241AC

P2860

Q33503319-0BAAEBB4-D71F-4DD3-8928-2C1C65CD13C3

Q33503319-171F43A9-17A7-46D3-969D-3F245DF6FAD7

Q33503319-1819BBE3-B546-400C-9DEE-2A3BDD56CC4A

Q33503319-218E732F-908F-4F99-90C1-EE353E15D94E

Q33503319-3C340C2B-2D25-4B9F-A1A3-CA5621DF4F28

Q33503319-552A382F-E3F6-400B-9712-3D9A1180D5A0

Q33503319-5FB802B0-5099-4800-99CA-9F4623633BBE

Q33503319-6EBC6C6C-75ED-43C8-9B41-24A2FD9F8FCD

Q33503319-7C68BA2A-1210-4285-B11A-E47625DD07FB

Q33503319-8D2E4DE2-1B27-4486-B20E-296B46A1868B

P304

Q33503319-A9A102B7-2067-47B5-B5B3-8884388E810F

P31

Q33503319-F71D60EE-326B-4D3B-A2C4-8FDA90ACF6D6

P356

Q33503319-C1A1C156-92FC-408D-9CC4-46C33FA1F29C

P433

Q33503319-884C8286-AEBE-47B7-AD4C-F6E19A12E26D

P478

Q33503319-C93F64E0-766F-47CA-9F1B-5E6CE30ECC27

P577

Q33503319-136B99F5-769E-4849-8A12-F1D47A250CFF

P698

Q33503319-58A5C958-F39F-474D-AE4B-BB4D55E63603

P356

153303460900800502

P1433

Technology in Cancer Research and Treatment

P1476

Protein profiling of pleural e ...... sothelioma using SELDI-TOF MS.

@en

P2093

Bart N Lambrecht

http://www.w3.org/2001/XMLSchema#string

Curtis Glover

http://www.w3.org/2001/XMLSchema#string

Davy T'Jampens

http://www.w3.org/2001/XMLSchema#string

Eric T Fung

http://www.w3.org/2001/XMLSchema#string

Fujun Zhang

http://www.w3.org/2001/XMLSchema#string

Henk C Hoogsteden

http://www.w3.org/2001/XMLSchema#string

Joachim Aerts

http://www.w3.org/2001/XMLSchema#string

Joost P J J Hegmans

http://www.w3.org/2001/XMLSchema#string

Joris D Veltman

http://www.w3.org/2001/XMLSchema#string

Thorsten Verch

http://www.w3.org/2001/XMLSchema#string

P2860

MESOMARK: a potential test for malignant pleural mesothelioma

Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer

Molecular cloning and expression of megakaryocyte potentiating factor cDNA

Diagnosis of multiple cancer types by shrunken centroids of gene expression

Comprehensive analysis of HE4 expression in normal and malignant human tissues.

Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: a detailed systematic analysis using published data.

Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy.

Inflammatory protein profile during systemic high dose interleukin-2 administration.

Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry.

The cytology of malignant mesothelioma.

P304

323-332

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/153303460900800502

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19754208

http://www.w3.org/2001/XMLSchema#string